When $AGL Agilon Health promised strong 2025 numbers, investors listened. But a sudden CEO exit, scrapped financial guidance, and a massive earnings miss sent shares plunging over 50%. In this episode of Sue Wall Street: Holding Wall Street Accountable, we dive deep into the class action lawsuit accusing $AGL of misleading shareholders. If you're an investor, finance buff, or legal drama fan this one's for you. We break it down with sharp analysis and a touch of humor.
Visit ZLK.com for more info.
Add our WhatsApp Channel.
We’re not lawyers or accountants, so don’t take this as legal or financial advice.
